DBV Technologies S.A.
DBV Technologies S.A. (DBVT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DBVT · as of Jun 8, 2026
Key Statistics
Explore DBV Technologies S.A. Data
dbvt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 66.7%
The DBVT analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $46.33, representing +179.26% upside from the current price of $16.59.
Competitors & Peers
dbvt competitorsDBVT
ALT
AMRN
ANNX
ANRO
CLLSStock Performance
Full HistoryAbout DBV Technologies S.A.
DBV Technologies S.A. a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immu…
what is dbv technologies s.a. · dbvt stock overview · dbv technologies s.a. company profile · who is dbv technologies s.a. ceo · dbvt NASDAQ · dbv technologies s.a. headquarters · dbv technologies s.a. business segments
About Stock Overview & Key Data
DBV Technologies S.A. (DBVT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 22, 2014. As of the latest trading session, DBVT stock price is $16.59, with a market capitalization of $396.9M. The stock has returned +91.13% over the past 12 months and -13.46% year-to-date.
According to 15 Wall Street analysts, the consensus rating for DBV Technologies S.A. stock is Buy, with an average 12-month price target of $46.33. In fiscal year 2025, DBV Technologies S.A. reported revenue of — and net income of -$146.9M. For detailed data — including DBV Technologies S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DBV Technologies S.A. (DBVT) stock price is $16.59. The stock is traded on NASDAQ under the ticker symbol DBVT. The 52-week range is $8.30 – $26.18.